Prenatal and New-born Genetic Testing Market forecast
Prenatal and New-born Genetic Testing Market Trend to 2024 Profiling Ariosa Diagnostics, Berry Genomics, BGI, Biorad, Illumina, Laboratory Corporation of America, Natera, Qiagen, Sequenom & More
MarketStudyReport.com Adds New Prenatal and New-born Genetic Testing Market 2018 – 2024 research report providing information and By Technology, By Disease, By End-use, Industry Analysis, By Technology, Regional Outlook, Growth Potential, Trends, Competitive Market Share & Forecast spreading across 140 Pages with table and figures in it.
Prenatal and New-born Genetic Testing Market Research Report for the period of 2018-2024 that shows the growth of the market is rising at a 11.9% CAGR to 2024.
Prenatal and New-born Genetic Testing Market will exceed USD 7 billion by 2024; as per a new research report. Technological advancement and several benefits associated with infant genetic testing will be major driver of the prenatal and new-born genetic testing market. Introduction of prenatal testing has led to substantial amount of increase in adoption rate of new testing technologies such as non-invasive prenatal testing (NIPT) for detection of sub chromosomal abnormalities, single-gene disorders and aneuploidy in North America region. Inclination towards minimally invasive infant genetic testing along with demand for early detection of birth defects will one of the major reason for market growth.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1130963/
Rising number of consanguineous relations in the developing countries of Asia and Middle East will foster growth opportunities for prenatal and newborn genetic testing market. The consanguineous relations are responsible for births of infants with defects and chromosomal abnormalities. Consequent, the increase in cases of live births diagnosed with birth defects will directly impact the growth of prenatal and new-born genetic testing market.
Increasing prevalence of birth defects among the European population is one of the major reason for rising infant mortality. The necessary government initiatives in order to conduct prenatal and new-born genetic tests to diagnose the birth defects will increase the number of infant screening programs giving rise to market growth opportunities.
Screening technology holds majority of market share in the year 2017 owing to increasing number of screening procedures of pregnant women while delivery. The rise in awareness among the families regarding genetic birth defects and early detection of genetic disorder will augment the segment growth in the near future.
Downs Syndrome recorded largest market share in the prenatal and newborn genetic testing market due to increasing in number of births diagnosed with Downs syndrome. The rise in incidences of women getting married at later stage of life is leading to increasing births with Downs Syndrome. These factors will further support the segment growth over the forecast timeframe.
Hospitals hold the majority of market share owing to increasing number of births in hospitals. Hospitals are aided by the government and provide the facilities require for the newborn screening. The increase in number of screening programs in hospitals provides significant scope for the market growth.
U.S. dominated the market in 2017 owing to ongoing technological advancements along with favorable reimbursement policies. The U.S. region had 99% of newborn screening rate and high awareness about prenatal and new-born genetic testing will be responsible for the market growth in U.S. Presence of technologically advanced and equipped manufacturing companies along with government initiatives supporting screening activities that will impel market growth.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1130963/
Some of the major market players competing in global prenatal and newborn genetic testing market are Ariosa Diagnostics (Roche), Berry Genomics, BGI, Biorad, Illumina, Laboratory Corporation of America, Natera, Qiagen, Sequenom, Trivitron Healthcare and Verinata health. The competitors are using launch of novel products with technological advancements, acquisitions and mergers as the key strategies to foresee a lucrative growth in prenatal and newborn genetic testing market. For example, In March 2018, Natera declared a partnership with QIAGEN to develop cell-free DNA assays for QIAGEN’s GeneReader NGS System. These DNA assays will be developed and designed for tests, including prenatal screening, for laboratories and hospitals globally.
Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Prenatal and New-born Genetic Testing Industry Insights
Chapter 4. Prenatal and New-born Genetic Testing Market, By Technology
Chapter 5. Prenatal and New-born Genetic Testing Market, By Disease
Chapter 6. Prenatal and New-born Genetic Testing Market, By End-use
Chapter 6. Prenatal and New-born Genetic Testing Market, By Region
Chapter 7. Company Profiles
For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html
Global Prenatal and New-born Genetic Testing Market Size, Status and Forecast 2025
This report studies the global Prenatal and New-born Genetic Testing market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Prenatal and New-born Genetic Testing market by companies, region, type and end-use industry.
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
US Toll Free: 1-866-764-2150